Recursion Pharmaceuticals grants director Fred Hassan 156,658 restricted stock units
RXRX•Recursion Pharmaceuticals awarded director Fred Hassan 156,658 shares of Class A common stock on Nov. 2, 2026.
1. Stock award
Recursion Pharmaceuticals awarded director Fred Hassan 156,658 shares of Class A common stock on Nov. 2, 2026.
